- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02489071
Cognitive Intervention After a Brain Tumor
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Cognitive impairments (including problems with attention, memory or executive functions) are common in people with brain tumors, as a result of the disease and/or treatment effects. These deficits, even when relatively mild, can interfere with interpersonal relationships, occupational activities, functional independence, and quality of life. They may also contribute to caregiver burden.
Building on research in other cognitively-impaired populations, in this study we compare two behavioural interventions. The Brain Training (BT) and Brain Health (BH) interventions each offer a structured yet client-centered program through 8 weekly individual treatment sessions and between-session exercises. Contents include mindfulness practice, strategy training, and supportive psychoeducation including counseling around lifestyle factors to promote brain functioning.
Using a prospective randomized controlled design, 54 brain tumor patients are being enrolled in one of three study arms: BT, BH, or standard care (wait-list control). A battery of outcome measures is being administered (1) prior to intervention, (2) after the 8-week behavioural intervention (or wait-list) period, and (3) after an additional 4 months to evaluate longer-term outcomes. Analyses of variance will examine treatment effects, with regression analyses to explore moderating effects of participant demographics, severity of baseline cognitive impairment, and tumor and treatment factors (e.g., tumor location, radiation dose and distribution). Results of this trial will lay the groundwork for implementation of evidence-based supportive care to reduce and manage cognitive impairments following a brain tumor.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M5S1W8
- Princess Margaret Cancer Centre
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- age 18 or older
- fluent in English
- able to provide informed consent to all procedures
- diagnosis of a brain tumor
- indication of lasting post-treatment cognitive deficits (e.g., from clinical presentation, prior neuropsychological assessment, and/or self-report)
- sufficient motor and sensory functioning to complete study activities
- availability to complete all study activities
- for patients treated with cranial radiation, at least 3 months post-radiation
Exclusion Criteria:
(1) comorbid neurological or psychiatric disorder or other medical condition suspected to influence cognition
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Brain Training
8-session cognitive training program
|
|
Experimental: Brain Health
8-session cognitive education program
|
|
No Intervention: Control
Wait-list control group
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in cognitive composite score
Time Frame: baseline, 2 months (0-2 weeks post-training), 6 months (4 months post-training)
|
Summation of standardized change scores on neuropsychological tests
|
baseline, 2 months (0-2 weeks post-training), 6 months (4 months post-training)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in functional composite score
Time Frame: baseline, 2 months (0-2 weeks post-training), 6 months (4 months post-training)
|
Summation of standardized change scores on measures of occupational functioning
|
baseline, 2 months (0-2 weeks post-training), 6 months (4 months post-training)
|
Change in quality of life composite score
Time Frame: baseline, 2 months (0-2 weeks post-training), 6 months (4 months post-training)
|
Summation of standardized change scores on measures of affect, perceived self-efficacy, and illness burden
|
baseline, 2 months (0-2 weeks post-training), 6 months (4 months post-training)
|
Change in caregiver quality of life composite score
Time Frame: baseline, 2 months (0-2 weeks post-training), 6 months (4 months post-training)
|
Summation of standardized change scores on measures of affect and caregiver burden
|
baseline, 2 months (0-2 weeks post-training), 6 months (4 months post-training)
|
Collaborators and Investigators
Investigators
- Principal Investigator: Kim Edelstein, PhD, Princess Margaret Cancer Centre, University Health Network
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 13-7277-CE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Brain Tumors
-
University of FloridaCompletedCentral Nervous System TumorsUnited States
-
Children's Hospital Los AngelesUnknownBrain and Central Nervous System TumorsUnited States, Canada, Australia, Switzerland, New Zealand
-
St. Jude Children's Research HospitalCompletedBrain Tumors | Central Nervous System TumorsUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedBrain Tumors | Central Nervous System TumorsUnited States, Australia, Canada
-
Emory UniversityNational Cancer Institute (NCI)CompletedBrain and Central Nervous System TumorsUnited States
-
Abramson Cancer Center of the University of PennsylvaniaNational Cancer Institute (NCI)CompletedBrain and Central Nervous System TumorsUnited States
-
Duke UniversityNational Cancer Institute (NCI)CompletedBrain and Central Nervous System TumorsUnited States
-
M.D. Anderson Cancer CenterTerminatedBrain Tumors | Central Nervous System TumorsUnited States
-
Pediatric Brain Tumor ConsortiumNational Cancer Institute (NCI)CompletedVNP40101M in Treating Young Patients With Recurrent, Progressive, or Refractory Primary Brain TumorsBrain and Central Nervous System TumorsUnited States
-
Children's Hospital Medical Center, CincinnatiTerminatedSolid Tumors | Brain TumorsUnited States
Clinical Trials on Brain Training Program
-
The University of Texas at DallasUniversity of Texas Southwestern Medical CenterCompleted
-
George Mason UniversityCompleted
-
BaycrestCentre for Aging and Brain Health InnovationCompletedAging | Cognitive DeclineCanada
-
The University of Texas at DallasRecruiting
-
i-Function, Inc.Active, not recruitingHealthy Aging | Mild Cognitive ImpairmentUnited States
-
Stanford UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedPremature BirthUnited States
-
Stanford UniversityCompletedAttention Deficit Hyperactivity DisorderUnited States
-
Posit Science CorporationCompleted
-
Posit Science CorporationMayo Clinic; University of Southern CaliforniaCompleted
-
Posit Science CorporationCompleted